Arsenal Medical, a clinical-stage company pioneering innovative biomaterials-based devices, announced the first patient treated with a first-of-its-kind device, ResQFoam™, in the REVIVE clinical study at the University of Alabama at Birmingham (UAB).
Related: TECLens begins...
Arsenal Medical, a clinical-stage company pioneering innovative biomaterials-based devices, announced the first patient treated with a first-of-its-kind device, ResQFoam™, in the REVIVE clinical study...
Airiver Medical announced that it received FDA breakthrough device designation for its pulmonary drug-coated balloon (DCB).
Additionally, Airiver announced the first treated patients in a...
Polares Medical announced that it closed a $50 million Series C financing round to support its heart leaflet replacement system.
Lausanne, Switzerland-based Polares designed its...
Xsensio announced that it closed a $7 million oversubscribed Series A financing round to support its patient monitoring technology.
The Lausanne, Switzerland-based company develops technology...
Arsenal Medical, a clinical-stage company pioneering innovative biomaterials-based devices, announced the first patient treated with a first-of-its-kind device, ResQFoam™, in the REVIVE clinical study...
TECLens has commenced the first-in-human clinical trial assessing its quantitative corneal crosslinking (qCXL) technology for non-invasive refractive vision correction, administering treatment to the initial...
VESTECK announced that implanting clinicians will present two-year follow-up data from the company’s first-in-human experience with the SUTURE-TIGHT™ Endovascular Catheter System, an adjunctive fixation...
Kandu Health announced positive results from the first randomized controlled trial of its brain-computer interface (BCI) therapy.
The trial evaluated its FDA-cleared, non-invasive IpsiHand BCI...
Arsenal Medical, a clinical-stage company pioneering innovative biomaterials-based devices, announced the first patient treated with a first-of-its-kind device, ResQFoam™, in the REVIVE clinical study...
Airiver Medical announced that it received FDA breakthrough device designation for its pulmonary drug-coated balloon (DCB).
Additionally, Airiver announced the first treated patients in a...
Polares Medical announced that it closed a $50 million Series C financing round to support its heart leaflet replacement system.
Lausanne, Switzerland-based Polares designed its...
Xsensio announced that it closed a $7 million oversubscribed Series A financing round to support its patient monitoring technology.
The Lausanne, Switzerland-based company develops technology...